Given's M2A "endoscopy pill" gets more positive trial data
This article was originally published in Clinica
Trial data have shown that Given Imaging's swallowable "video pill" can detect up to 80% of small bowel abnormalities, a significantly greater percentage than found using traditional methods, according to the company. The data also revealed that the device, called the M2A capsule endoscope, could be useful for diagnosing more conditions.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.